Subcutaneous Study Drug

· Palatin Technologies, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Subcutaneous Study Drug, covering 2014-12-16 to 2014-12-16. Get the full timeline:

Most recent: Clinical Trial Update: Cross-Over Study of Subcutaneous Study Drug for the Treatment of Patients With Mild to Moderate Asthma [Phase 2]